In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News BPC 157 aka Wolverine. This peptide is not FDA approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesn't have human data yet, so